We are analyzing https://link.springer.com/article/10.1007/s007020200068.

Title:
Alzheimer disease and cerebrovascular pathology: an update | Journal of Neural Transmission
Description:
Recent epidemiological and clinico-pathologic data suggest overlaps between Alzheimer disease (AD) and cerebrovascular lesions that may magnify the effect of mild AD pathology and promote progression of cognitive decline or even may precede neuronal damage and dementia.Vascular pathology in the aging brain and in AD includes: 1. cerebral amyloid angiopathy (CAA) with an incidence of 82–98% often associated with ApoEε2 and causing a) cerebral mass hemorrhages (around 70%, mainly in the frontal and parieal lobes), b) multiple or recurrent microhemorrhages (15%), and c) ischemic (micro-)infarcts or lacunes (around 20%). The frequency of these lesions increases with the severity of CAA and shows no correlation with that of senile amyloid plaques. CAA, significantly more frequent in patients with cerebral hemorrhages or infarcts than in aged controls, is an important risk factor for cerebrovascular lesions in AD. 2. Microvascular changes with decreased density and structural abnormalities causing regional metabolic and blood-brain barrier dysfunctions with ensuing neuronal damage. In large autopsy series of demented aged subjects, around 80% show Alzheimer type pathology, 20–40% with additional, often minor vascular lesions, 7–10% “pure” vascular dementia, and 3–5% “mixed” dementia (combination of AD and vascular encephalopathy). AD cases with additional minor cerebrovascular lesions have significantly more frequent histories of hypertension or infarcts than “pure” AD patients. Vascular lesions in AD include cortical microinfarcts, subcortial lacunes, white matter lesions / leukoencephalopathy, small hemorrhages and corticosubcortical infarcts, while in mixed type dementia multiple larger or hemispheral infarcts are more frequent. Small infarcts in AD patients have no essential impact on global cognitive decline which mainly depends on the severity of Alzheimer pathology, but in early stage of AD they may influence and promote the development of dementia. Recent studies showed lower density of plaques and tangles in brains with cerebrovascular lesions, and similar severity of dementia was related to fewer AD lesions in brains with than in those without small vascular lesions. Further studies will help to elucidate the risk factors and impact of cerebrovascular lesions on the development and progression of dementia in AD.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Social Networks
Mobile Technology & AI

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,734,772 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

lesions, article, cerebrovascular, dementia, pathology, alzheimer, cerebral, vascular, privacy, cookies, content, journal, disease, amyloid, infarcts, data, information, publish, search, angiopathy, patients, access, log, research, neural, jellinger, caa, hemorrhages, multiple, severity, frequent, subjects, type, additional, mixed, small, impact, related, disorders, discover, springer, essential, optional, personal, parties, policy, find, track, transmission, update,

Topics {✒️}

concomitant neurological disorders cerebral amyloid angiopathy blood-brain barrier dysfunctions month download article/chapter privacy choices/manage cookies minor vascular lesions alzheimer disease neural transmission aims senile amyloid plaques cerebral mass hemorrhages small vascular lesions full article pdf 3–5% “mixed” dementia european economic area scope submit manuscript precede neuronal damage ensuing neuronal damage large autopsy series long-term outcome mild ad pathology conditions privacy policy important risk factor demented aged subjects fewer ad lesions cerebrovascular pathology accepting optional cookies global cognitive decline cerebrovascular lesions vascular pathology alzheimer pathology journal finder publish vascular lesions article jellinger �pure” ad patients cerebral hemorrhages microvascular personal data vascular encephalopathy 1007/s007020200068 keywords article journal privacy policy article log recent epidemiological decreased density books a lesions increases related subjects neural transm 109 data protection optional cookies

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Alzheimer disease and cerebrovascular pathology: an update
         description: Recent epidemiological and clinico-pathologic data suggest overlaps between Alzheimer disease (AD) and cerebrovascular lesions that may magnify the effect of mild AD pathology and promote progression of cognitive decline or even may precede neuronal damage and dementia.Vascular pathology in the aging brain and in AD includes: 1. cerebral amyloid angiopathy (CAA) with an incidence of 82–98% often associated with ApoEε2 and causing a) cerebral mass hemorrhages (around 70%, mainly in the frontal and parieal lobes), b) multiple or recurrent microhemorrhages (15%), and c) ischemic (micro-)infarcts or lacunes (around 20%). The frequency of these lesions increases with the severity of CAA and shows no correlation with that of senile amyloid plaques. CAA, significantly more frequent in patients with cerebral hemorrhages or infarcts than in aged controls, is an important risk factor for cerebrovascular lesions in AD. 2. Microvascular changes with decreased density and structural abnormalities causing regional metabolic and blood-brain barrier dysfunctions with ensuing neuronal damage. In large autopsy series of demented aged subjects, around 80% show Alzheimer type pathology, 20–40% with additional, often minor vascular lesions, 7–10% “pure” vascular dementia, and 3–5% “mixed” dementia (combination of AD and vascular encephalopathy). AD cases with additional minor cerebrovascular lesions have significantly more frequent histories of hypertension or infarcts than “pure” AD patients. Vascular lesions in AD include cortical microinfarcts, subcortial lacunes, white matter lesions / leukoencephalopathy, small hemorrhages and corticosubcortical infarcts, while in mixed type dementia multiple larger or hemispheral infarcts are more frequent. Small infarcts in AD patients have no essential impact on global cognitive decline which mainly depends on the severity of Alzheimer pathology, but in early stage of AD they may influence and promote the development of dementia. Recent studies showed lower density of plaques and tangles in brains with cerebrovascular lesions, and similar severity of dementia was related to fewer AD lesions in brains with than in those without small vascular lesions. Further studies will help to elucidate the risk factors and impact of cerebrovascular lesions on the development and progression of dementia in AD.
         datePublished:
         dateModified:
         pageStart:813
         pageEnd:836
         sameAs:https://doi.org/10.1007/s007020200068
         keywords:
            Keywords: Alzheimer disease
            cerebrovascular lesions
            cerebral amyloid angiopathy
            mixed type dementia
            microvascular pathology.
            Neurology
            Psychiatry
            Neurosciences
         image:
         isPartOf:
            name:Journal of Neural Transmission
            issn:
               1435-1463
               0300-9564
            volumeNumber:109
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:K. A. Jellinger
               affiliation:
                     name:Ludwig Boltzmann Institute of Clinical Neurobiology, Vienna, Austria
                     address:
                        name:Ludwig Boltzmann Institute of Clinical Neurobiology, Vienna, Austria, , AT
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Alzheimer disease and cerebrovascular pathology: an update
      description: Recent epidemiological and clinico-pathologic data suggest overlaps between Alzheimer disease (AD) and cerebrovascular lesions that may magnify the effect of mild AD pathology and promote progression of cognitive decline or even may precede neuronal damage and dementia.Vascular pathology in the aging brain and in AD includes: 1. cerebral amyloid angiopathy (CAA) with an incidence of 82–98% often associated with ApoEε2 and causing a) cerebral mass hemorrhages (around 70%, mainly in the frontal and parieal lobes), b) multiple or recurrent microhemorrhages (15%), and c) ischemic (micro-)infarcts or lacunes (around 20%). The frequency of these lesions increases with the severity of CAA and shows no correlation with that of senile amyloid plaques. CAA, significantly more frequent in patients with cerebral hemorrhages or infarcts than in aged controls, is an important risk factor for cerebrovascular lesions in AD. 2. Microvascular changes with decreased density and structural abnormalities causing regional metabolic and blood-brain barrier dysfunctions with ensuing neuronal damage. In large autopsy series of demented aged subjects, around 80% show Alzheimer type pathology, 20–40% with additional, often minor vascular lesions, 7–10% “pure” vascular dementia, and 3–5% “mixed” dementia (combination of AD and vascular encephalopathy). AD cases with additional minor cerebrovascular lesions have significantly more frequent histories of hypertension or infarcts than “pure” AD patients. Vascular lesions in AD include cortical microinfarcts, subcortial lacunes, white matter lesions / leukoencephalopathy, small hemorrhages and corticosubcortical infarcts, while in mixed type dementia multiple larger or hemispheral infarcts are more frequent. Small infarcts in AD patients have no essential impact on global cognitive decline which mainly depends on the severity of Alzheimer pathology, but in early stage of AD they may influence and promote the development of dementia. Recent studies showed lower density of plaques and tangles in brains with cerebrovascular lesions, and similar severity of dementia was related to fewer AD lesions in brains with than in those without small vascular lesions. Further studies will help to elucidate the risk factors and impact of cerebrovascular lesions on the development and progression of dementia in AD.
      datePublished:
      dateModified:
      pageStart:813
      pageEnd:836
      sameAs:https://doi.org/10.1007/s007020200068
      keywords:
         Keywords: Alzheimer disease
         cerebrovascular lesions
         cerebral amyloid angiopathy
         mixed type dementia
         microvascular pathology.
         Neurology
         Psychiatry
         Neurosciences
      image:
      isPartOf:
         name:Journal of Neural Transmission
         issn:
            1435-1463
            0300-9564
         volumeNumber:109
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:K. A. Jellinger
            affiliation:
                  name:Ludwig Boltzmann Institute of Clinical Neurobiology, Vienna, Austria
                  address:
                     name:Ludwig Boltzmann Institute of Clinical Neurobiology, Vienna, Austria, , AT
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neural Transmission
      issn:
         1435-1463
         0300-9564
      volumeNumber:109
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Ludwig Boltzmann Institute of Clinical Neurobiology, Vienna, Austria
      address:
         name:Ludwig Boltzmann Institute of Clinical Neurobiology, Vienna, Austria, , AT
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:K. A. Jellinger
      affiliation:
            name:Ludwig Boltzmann Institute of Clinical Neurobiology, Vienna, Austria
            address:
               name:Ludwig Boltzmann Institute of Clinical Neurobiology, Vienna, Austria, , AT
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Ludwig Boltzmann Institute of Clinical Neurobiology, Vienna, Austria, , AT
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(25)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.63s.

LINK . SPRINGER . COM {}